S&P 500   3,123.99 (-0.13%)
DOW   27,007.51 (-0.27%)
QQQ   216.31 (+0.44%)
AAPL   291.81 (+1.29%)
FB   196.91 (+0.07%)
MSFT   169.92 (+1.10%)
GOOGL   1,386.51 (+0.01%)
AMZN   1,975.00 (+0.11%)
NVDA   267.61 (+2.12%)
BABA   208.61 (+1.46%)
MU   52.23 (+0.25%)
GE   10.89 (-3.80%)
TSLA   786.45 (-1.68%)
AMD   47.74 (+0.36%)
T   37.24 (-0.29%)
F   7.25 (+0.14%)
NFLX   376.09 (+4.44%)
BAC   30.63 (-1.45%)
DIS   122.70 (-4.28%)
GILD   74.23 (+5.89%)
S&P 500   3,123.99 (-0.13%)
DOW   27,007.51 (-0.27%)
QQQ   216.31 (+0.44%)
AAPL   291.81 (+1.29%)
FB   196.91 (+0.07%)
MSFT   169.92 (+1.10%)
GOOGL   1,386.51 (+0.01%)
AMZN   1,975.00 (+0.11%)
NVDA   267.61 (+2.12%)
BABA   208.61 (+1.46%)
MU   52.23 (+0.25%)
GE   10.89 (-3.80%)
TSLA   786.45 (-1.68%)
AMD   47.74 (+0.36%)
T   37.24 (-0.29%)
F   7.25 (+0.14%)
NFLX   376.09 (+4.44%)
BAC   30.63 (-1.45%)
DIS   122.70 (-4.28%)
GILD   74.23 (+5.89%)
S&P 500   3,123.99 (-0.13%)
DOW   27,007.51 (-0.27%)
QQQ   216.31 (+0.44%)
AAPL   291.81 (+1.29%)
FB   196.91 (+0.07%)
MSFT   169.92 (+1.10%)
GOOGL   1,386.51 (+0.01%)
AMZN   1,975.00 (+0.11%)
NVDA   267.61 (+2.12%)
BABA   208.61 (+1.46%)
MU   52.23 (+0.25%)
GE   10.89 (-3.80%)
TSLA   786.45 (-1.68%)
AMD   47.74 (+0.36%)
T   37.24 (-0.29%)
F   7.25 (+0.14%)
NFLX   376.09 (+4.44%)
BAC   30.63 (-1.45%)
DIS   122.70 (-4.28%)
GILD   74.23 (+5.89%)
S&P 500   3,123.99 (-0.13%)
DOW   27,007.51 (-0.27%)
QQQ   216.31 (+0.44%)
AAPL   291.81 (+1.29%)
FB   196.91 (+0.07%)
MSFT   169.92 (+1.10%)
GOOGL   1,386.51 (+0.01%)
AMZN   1,975.00 (+0.11%)
NVDA   267.61 (+2.12%)
BABA   208.61 (+1.46%)
MU   52.23 (+0.25%)
GE   10.89 (-3.80%)
TSLA   786.45 (-1.68%)
AMD   47.74 (+0.36%)
T   37.24 (-0.29%)
F   7.25 (+0.14%)
NFLX   376.09 (+4.44%)
BAC   30.63 (-1.45%)
DIS   122.70 (-4.28%)
GILD   74.23 (+5.89%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 PsychemedicsPotNetworkMiragen TherapeuticsBioceptAvant Diagnostics
SymbolNASDAQ:PMDOTCMKTS:POTNNASDAQ:MGENNASDAQ:BIOCOTCMKTS:AVDX
Price Information
Current Price$8.68$0.02$0.76$0.30$0.03
52 Week RangeN/AN/ABuyBuyN/A
Analyst Ratings
Consensus RecommendationN/AN/ABuyBuyN/A
Consensus Price TargetN/AN/A$6.50$1.00N/A
% Upside from Price TargetN/AN/A755.26% upside233.33% upsideN/A
Trade Information
Market Cap$48.66 million$16.38 million$25.26 million$14.65 million$10.78 million
Beta0.742.981.031.529.42
Average Volume19,9781,004,1345,087,9492,922,7044,936
Sales & Book Value
Annual Revenue$37.68 millionN/A$8.39 million$3.25 million$250,000.00
Price / Sales1.27N/A2.884.4043.13
Cashflow$1.37 per shareN/AN/AN/AN/A
Price / Cash6.35N/AN/AN/AN/A
Book Value$3.40 per shareN/A$1.66 per share$0.66 per share$0.01 per share
Price / Book2.55N/A0.460.453.20
Profitability
Net Income$1.54 millionN/A$-32,700,000.00$-24,570,000.00$-2,370,000.00
EPSN/AN/A($1.10)N/AN/A
Trailing P/E Ratio31.000.00N/AN/A0.00
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins4.09%N/A-1,037.02%-552.54%N/A
Return on Equity (ROE)13.22%N/A-113.02%-268.76%-143.01%
Return on Assets (ROA)9.39%N/A-80.64%-156.38%-51.41%
Dividend
Annual Payout$0.72N/AN/AN/AN/A
Dividend Yield8.29%N/AN/AN/AN/A
Three-Year Dividend Growth6.27%N/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend Growth2 YearsN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.05%N/A0.23%0.13%N/A
Current Ratio2.88%N/A3.68%1.83%0.02%
Quick Ratio2.88%N/A3.68%1.71%0.02%
Ownership Information
Institutional Ownership Percentage47.79%0.01%28.42%2.16%0.03%
Insider Ownership Percentage11.20%4.20%5.30%0.32%38.01%
Miscellaneous
Employees2501377952
Shares Outstanding5.52 million727.84 million31.79 million47.62 million336.96 million
Next Earnings Date4/28/2020 (Estimated)N/A3/11/2020 (Confirmed)3/26/2020 (Estimated)N/A
OptionableNot OptionableNot OptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel